Table 2. Comparison of BDCS and FTHS clinical features.
Borrone Dermato-Cardio-Skeletal Syndrome | Frank-ter haar Syndrome | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Family | BDCS 1 | BDCS 31 | BDCS 3 | BDCS 22 | BDCS 2 | FTHS 22 | FTHS 2 | FTHS 612, 16 | FTHS 712, 17 | FTHS 7 |
Patient | 1–17 | 3–3 | 3–4 | 2–2 | 2–3 | 1 | 2 | 1 | 1 | 2 |
Gender | M | M | M | M | M | M | M | F | M | F |
Max. age of symptom report | 8 years | 36 years | 23 years | 19 years | 17 years | 5.5 years | 1 yr | 6.4 years | 13 months | 34 days |
Age at death (years) | 8 | − | 24 | − | − | − | 1 | − | − | − |
Mutation detected | ||||||||||
SH3PXD2B | c.401+1G>A | c.1188+1773_2733+6592del | c.1188+1773_2733+6592del | − | − | c.147insT | c.147insT | c.969delG | Deletiona | Deletiona |
Protein alteration | p.(Glu134Glufs*1) | LP | LP | − | − | p.(F49*) | p.(F49*) | p.(G323fs*19) | LP | LP |
Developmental anomalies | ||||||||||
Motor retardation | − | − | − | − | − | + | + | + | + | + |
Craniofacial abnormalities | ||||||||||
Acne | − | + | + | + | + | NR | NR | NR | NR | NR |
Coarse face and thick skin | + | + | + | + | + | NR | NR | + | NR | NR |
Gingival enlargement | + | + | + | − | − | + | NR | NR | + | + |
Prominent forehead | + | + | + | + | + | + | + | + | + | + |
Brachycephaly | + | + | NR | NR | NR | + | + | + | + | + |
Wide anterior fontanel | NR | NR | NR | NR | NR | + | + | + | + | + |
Hypertelorism | + | + | + | + | + | + | NR | + | + | + |
Congenital glaucoma | − | NR | NR | NR | NR | + | NR | − | + | + |
Large cornea | − | NR | NR | NR | NR | + | NR | + | + | + |
Prominent eyes | + | NR | NR | − | − | + | + | + | + | + |
Full cheeks | + | + | + | + | + | + | + | + | + | + |
Anteverted nostrils | − | + | + | − | − | NR | + | − | + | + |
Broad mouth | + | + | + | + | + | + | + | + | + | + |
Broad alveolar ridges | + | NR | NR | NR | NR | NR | NR | + | + | + |
Micrognathia | + | + | + | − | − | + | + | − | + | + |
Protruding ears | − | + | NR | − | − | + | + | + | − | − |
Cardiac deficiencies | ||||||||||
Mitral valve anomaly | + | + | + | + | + | + | NR | + | NR | NR |
Double right outlet | − | − | − | − | − | NR | + | − | NR | NR |
Ventricular septal defect | − | − | − | − | − | NR | NR | + | − | + |
Skeletal abnormalities | ||||||||||
Vertebral anomalies | + | + | + | + | − | + | − | − | NR | NR |
Prominent coccyx | − | − | − | − | − | + | + | + | + | + |
Bowing of long bones | + | + | − | − | − | + | + | − | + | + |
Short hands | + | + | + | + | + | + | + | + | + | + |
Flexion deformity | + | + | + | + | + | − | − | + | + | + |
Club feet | + | − | − | − | − | + | − | PA | + | + |
Bone abnormalities | ||||||||||
Osteopenia | Cortical erosions | Cortical erosions | Cortical erosions | NR | Cortical anomalies | Cortical anomalies | Osteopenia | Osseous defects | Osseous defects | |
Osteoporosis | Osteoporosis | |||||||||
Osteolytic lesions | ||||||||||
Arthropathy | ||||||||||
Additional clinical features | ||||||||||
Genu valgum | Irregular tongue | Gynecomastia | Umbilical hernia | Muscle weakness Irregular contoured ribs | Hypotonia | Gall stones | Pectus excavatum | Pectus excavatum | ||
Radial head dislocation | Inguinal hernia | Thickening of interphalangeal joints | Thickening of interphalangeal joints | Joint hypermobility | Small pituitary | |||||
Thoracic wall deformity | Genu recurvatum | Inguinal hernia | Wormian bones | |||||||
Thickened interphalangeal joints | Loose skin | |||||||||
Digital fetal pads | ||||||||||
Hirsutism |
Abbreviations: LP, loss of protein; M, male; NR, not reported; PA, pes adductus.
The reported clinical features of BDCS and FTHS cases affected by an SH3PXD2B mutation were tabulated for comparison; only cases with a published report describing the patient phenotype were included. The table highlights the phenotypic variability reported in BDCS/FTHS despite the common occurrence of truncating loss of protein mutations. This variability may be partially accounted for by the documentation of follow-up consultations to monitor the disease progression, indicated by the maximum (Max.) age of symptom reports and also the patients age at death.
The deletion occurring in FTHS family 7 incorporated SH3PXD2B and UBTD2. The deletion of the two genes did not obviously alter the phenotype in comparison with patients carrying only a SH3PXD2B truncating mutation.17